Cenra Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chih-Yung Wu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.9yrs |
| CEO ownership | 0.00001% |
| Management average tenure | no data |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50
Jul 12
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching
Apr 25We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On
Mar 17China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 24Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?
Jan 27
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On
Dec 16China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 26CEO
Chih-Yung Wu
3.9yrs
Tenure
Mr. Chih-Yung Wu is President and Manager of China Chemical & Pharmaceutical Co., Ltd. since November 5, 2020. Mr. Wu was Technology Director & Vice President of R&D at China Chemical & Pharmaceutical Co.,...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 8.3yrs | no data | no data | |
| Representative Director | 4.7yrs | no data | 3.11% NT$ 186.9m | |
| Representative Chairman | 3.8yrs | no data | 1.61% NT$ 96.4m | |
| Independent Director | 3.3yrs | no data | no data | |
| Independent Director | 2.3yrs | no data | no data |
3.8yrs
Average Tenure
Experienced Board: 1701's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/04 05:46 |
| End of Day Share Price | 2024/09/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cenra Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Zheng Kit | Citigroup Inc |
| Ryan Liu | IBTS Investment Consulting Co., Ltd. |
| Regina Lee | Jih Sun Securities Investment Consulting Co., Ltd. |